TFF Pharmaceuticals Inc (TFFP)
2.69
-0.04
(-1.47%)
USD |
NASDAQ |
May 01, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
TFF Pharmaceuticals Cash and Short Term Investments (Quarterly): 5.478M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.478M |
| September 30, 2023 | 9.726M |
| June 30, 2023 | 7.663M |
| March 31, 2023 | 12.22M |
| December 31, 2022 | 16.61M |
| September 30, 2022 | 13.15M |
| June 30, 2022 | 20.89M |
| March 31, 2022 | 26.41M |
| December 31, 2021 | 33.79M |
| September 30, 2021 | 44.72M |
| Date | Value |
|---|---|
| June 30, 2021 | 52.07M |
| March 31, 2021 | 58.06M |
| December 31, 2020 | 35.30M |
| September 30, 2020 | 41.62M |
| June 30, 2020 | 21.92M |
| March 31, 2020 | 25.73M |
| December 31, 2019 | 28.09M |
| September 30, 2019 | 10.55M |
| June 30, 2019 | 13.63M |
| December 31, 2018 | 10.26M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.478M
Minimum
Dec 2023
58.06M
Maximum
Mar 2021
25.14M
Average
21.92M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 19.09M |
| Jaguar Health Inc | 6.469M |
| Genprex Inc | 6.738M |
| Aquestive Therapeutics Inc | 23.87M |
| NovaBay Pharmaceuticals Inc | 3.13M |